National Institutes of Health

Title Due Date Maximum Award Amount Description
NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed) Varies

The purpose of the MSPP is to develop a diverse pool of combined-degree students (e.g., MD/PhD, DDS/PhD, DVM/PhD) who have conducted their PhD dissertation research at research laboratories in the NIH Intramural Research Program. The recipients will receive rigorous training in the basic, translational, and clinical biomedical sciences to prepare them for leadership positions in biomedical careers. The research and training plans are expected to provide the recipients with a strong understanding of the rigorous research study design, critical thinking, experimental methods and rigor, quantitative approaches, bioethics, and data analysis. Training also includes a mentored research experience, and extensive career and professional development, mentoring, and networking opportunities planned and supported by the program. This program thus provides the knowledge, professional skills, and experiences required to identify and transition into careers in the biomedical research workforce that utilize the combined degree.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346733
Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) $275,000.00

The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications on chronic conditions understudied among women and/or that disproportionately affect populations of women who are understudied, underrepresented, and underreported in biomedical Research should align with Goal 1 of the 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women." The awards under this FOA will be administered by NIH ICs using funds that have been made available through the Office of Research on Womens Health (ORWH) and the scientific partnering Institutes and Centers across NIH.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346722
Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required) $750,000.00

The purpose of this RFA is to support the development and testing of primary care practice- and health system-level interventions and strategies to promote high quality care for adult cancer survivors during and/or after cancer treatment.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346726
Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional) $350,000.00

The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications on chronic conditions understudied among women and/or that disproportionately affect populations of women who are understudied, underrepresented, and underreported in biomedical Research should align with Goal 1 of the 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women." The awards under this FOA will be administered by NIH ICs using funds that have been made available through the Office of Research on Womens Health (ORWH) and the scientific partnering Institutes and Centers across NIH.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346672
Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) Varies

The purpose of this funding opportunity announcement (FOA) is to provide investigators with access to resources provided by the Data Management Coordinating Center for Diagnostic Centers of Excellence (RFA-NS-22-051), as part of the next phase of the Undiagnosed Diseases Network. Resources include infrastructure, data management, and clinical research support for a new Network of clinical sites that provide diagnostic services for patients with undiagnosed diseases.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346664
SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed) Varies

This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to further the development of Technology-enhanced training products for the health and safety training of: hazardous materials (HAZMAT) workers; waste treatment personnel; skilled support personnel associated with an emergency/disaster; emergency responders in biological hazard response, infectious disease response, and medical waste cleanup; emergency responders in disasters; and worker resiliency training. Technology-enhanced training products as defined by the Worker Training Program (WTP) include, but are not limited to, supporting training through various venues such as online training, mobile device training, virtual reality, and serious gaming. These advanced technologies complement all phases of training that can enhance, supplement, improve, and provide health and safety training for hazardous materials workers. These products must complement the goals and objectives of the WTP. The major objective of the NIEHS WTP is to prevent work related harm by training workers in how best to protect themselves and their communities from exposure to hazardous materials. The financial support for this initiative comes directly from NIEHS Worker Education and Training Branch SBIR funds.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346623
Genomic Community Resources (U24 Clinical Trial Not Allowed) Varies

The purpose of this initiative is to facilitate genomic research and to disseminate its products to the broader biomedical research community. NHGRI supports both new and existing genomic resources of demonstrated broad value to the research community. Awards under this FOA will support the development and distribution of genomic resources that will be valuable for both basic and clinical genomics research. Such resources include, but are not limited to, those that support: Genomic informatics toolsets, such as biomedical ontologies and analysis toolsets. Comprehensive identification and collections of genomic features, such as functional genomic elements and genetic assay results. Genomic community building efforts, such as standards development. Sample repositories for genomic studies, such as cell line repositories for high-value samples.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346565
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) $225,000.00

The purpose of this funding opportunity announcement (FOA) is to support translational and clinical research to (1) advance precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating persons, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating persons, fetuses, neonates, and children, including those with disabilities.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346551
Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional) $850,000.00

The purpose of this Funding Opportunity Announcement (FOA) is to solicit P20 planning grant applications for Climate Change and Health Research Centers (CCHRCs). This program will support the development of a transdisciplinary research environment to sustain a program of fundamental and applied research to examine the impacts of climate change on health and to develop action-oriented solutions to protect the health of individuals, communities, and nations from the hazards posed by climate change. This opportunity will allow development of new research teams collaborating with communities and other partners to develop projects that generate data that will build or expand research capacity across a range of thematic scientific areas in support of the four core tenets of the NIHs Initiative in climate heath research: health effects research, health equity, intervention research, and training and capacity building (https://www.nih.gov/sites/default/files/research-training/initiatives/c…).

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346548
Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed) Varies

This Funding Opportunity Announcement (FOA) invites grant applications aimed at elucidating neuroimmune and neuronal-glial pathophysiological mechanisms of HIV-associated neurological disorders (HAND) using ex vivo culturing platforms derived from human induced pluripotent stem cells (hiPSC) in the presence of addictive substances. Specific emphasis is on unbiased, reproducible analysis of genetics and epigenetics, neuroglial interactions, and neuroimmune cell activities from the single cell to neural circuit levels.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=346468